Mayo researchers: Dramatic outcomes in prostate cancer study
Saturday, June 20, 2009 - 09:14
in Health & Medicine
Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardised hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. In these two cases, physicians say the approach initiated the death of a majority of cancer cells and caused the tumours to shrink dramatically, allowing surgery. In both cases, the aggressive tumours had grown well beyond the prostate into the abdominal areas...
Read the whole article on Science Centric
More from Science Centric
Related
- Mayo researchers: Dramatic outcomes in prostate cancer studyFri, 19 Jun 2009, 15:11:50 EDT
- New tool helps physicians tailor hormone therapy for high-risk prostate cancer patientsTue, 23 Sep 2008, 14:09:26 EDT
- OHSU Cancer Institute finds that drug stimulated immune system in prostate cancerMon, 2 Jun 2008, 14:14:53 EDT
- Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatmentMon, 16 Mar 2009, 0:29:16 EDT
- Routine evaluation of prostate size not as effective in cancer screening, Mayo study findsTue, 10 Nov 2009, 11:24:51 EST